Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference

Wendy Damonte's Health Watch ReportsMore>>
Request Remind Me 2 Kit
Request a Remind Me 2 Kit
More >>
Blood Pressure Device
Blood Pressure Device
Updated: Monday, May 20 2013 1:21 PM EDT2013-05-20 17:21:07 GMT
Relief may be on the way for people with hard to treat high blood pressure. Researchers are testing a device they hope will be more effective than traditional medications.More >>
Relief may be on the way for people with hard to treat high blood pressure. Researchers are testing a device they hope will be more effective than traditional medications.More >>
Prostate Cancer Drug, Financial Tolls & Sweetened Drinks
Prostate Cancer Drug, Financial Tolls & Sweetened Drinks
Updated: Friday, May 17 2013 12:54 PM EDT2013-05-17 16:54:09 GMT
Too much soda can be bad for your kidneys and a new drug that could help some men with advanced prostate cancer.More >>
Too much soda can be bad for your kidneys and a new drug that could help some men with advanced prostate cancer.More >>
Painkillers & Men
Painkillers & Men
Updated: Thursday, May 16 2013 1:45 PM EDT2013-05-16 17:45:18 GMT
Millions of Americans use prescription painkillers to cope with chronic pain problems. But a new study shows taking the medications may have an unwanted side effect for men.More >>
Millions of Americans use prescription painkillers to cope with chronic pain problems. But a new study shows taking the medications may have an unwanted side effect for men.More >>
Breastfeeding With Formula
Breastfeeding With Formula
Updated: Wednesday, May 15 2013 1:14 PM EDT2013-05-15 17:14:57 GMT
Mothers who want to successfully breastfeed are usually urged to avoid any formula. But now a new study shows giving a little formula to some newborns may actually help moms keep breastfeeding.More >>
Mothers who want to successfully breastfeed are usually urged to avoid any formula. But now a new study shows giving a little formula to some newborns may actually help moms keep breastfeeding.More >>
BRCA Genetic Testing
BRCA Genetic Testing
Updated: Tuesday, May 14 2013 7:40 PM EDT2013-05-14 23:40:09 GMT
Angelina Jolie has opened up the conversation over prophylactic surgery following bad news from genetic testing.

More >>
Angelina Jolie had a prophylactic double mastectomy after getting genetic testing. Women with the same faulty BRCA gene as Jolie are at significantly increased risk of breast cancer and ovarian cancer.More >>
Angelina Jolie Says She Had Double Mastectomy
Angelina Jolie Says She Had Double Mastectomy
Updated: Tuesday, May 14 2013 4:42 PM EDT2013-05-14 20:42:55 GMT
Angelina Jolie has revealed she had a voluntary double mastectomy after discovering she has a gene that greatly increases her risks of getting breast cancer.More >>
Angelina Jolie has revealed she had a voluntary double mastectomy after discovering she has a gene that greatly increases her risks of getting breast cancer.More >>
Ask the Doctor: Prostate Cancer
Ask the Doctor: Prostate Cancer
Updated: Monday, May 13 2013 8:11 PM EDT2013-05-14 00:11:38 GMT
We're talking about prostate cancer in Monday's Ask the Doctor segment.More >>
We're talking about prostate cancer in Monday's Ask the Doctor segment.More >>
"Rock and Roll Program" Cuts Down on Number of C-Sections
"Rock and Roll Program" Cuts Down on Number of C-Sections
Updated: Monday, May 13 2013 6:31 PM EDT2013-05-13 22:31:34 GMT
As part of the program, nurses get women moving and have them change positions about every 30 minutes.More >>
As part of the program, nurses get women moving and have them change positions about every 30 minutes.More >>
Electronic Health Records
Electronic Health Records
Updated: Friday, May 10 2013 1:23 PM EDT2013-05-10 17:23:47 GMT
The medical profession is going digital. Many doctors still rely on paper and pen, a habit the new healthcare law is trying to break.More >>
The medical profession is going digital. Many doctors still rely on paper and pen, a habit the new healthcare law is trying to break.More >>

Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

SOURCE Keryx Biopharmaceuticals, Inc.

Presentation Scheduled for Wednesday, February 27th at 2:15 PM ET

NEW YORK, Feb. 22, 2013 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the Citigroup 2013 Global Healthcare Conference, being held February 25-27, 2013, in New York City. Mr. Bentsur's presentation is scheduled to take place on Wednesday, February 27^th, at 2:15 PM ET.

A live audio webcast of Mr. Bentsur's presentation will be accessible from the Investor Information page of the Company's Website at http://investors.keryx.com. An archived version of the webcast will be available following the conclusion of the live presentation.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease. Keryx is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex has completed a U.S.-based Phase 3 clinical program for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease, conducted pursuant to a Special Protocol Assessment (SPA) agreement with the FDA, and Keryx expects to submit an NDA with the FDA and a MAA with the EMA in the second quarter of 2013. Zerenex is also in Phase 2 development in the U.S. for the management of phosphorus and iron deficiency in anemic patients with Stage 3 to 5 non-dialysis dependent chronic kidney disease. In addition, Keryx's Japanese partner, Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. has filed its New Drug Application for marketing approval of ferric citrate in Japan for the treatment of hyperphosphatemia in patients with chronic kidney disease. Keryx is headquartered in New York City.

KERYX CONTACT:
Lauren Fischer
Director - Investor Relations
Keryx Biopharmaceuticals, Inc.
Tel: 212.531.5965
E-mail: lfischer@keryx.com

Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference - KTVN Channel 2 - Reno Tahoe News Weather, Video -

Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference

Wendy Damonte's Health Watch ReportsMore>>